3-(2-carboxypiperazine-4-yl)propyl-1-phosphate has been researched along with oxidopamine in 1 studies
| Studies (3-(2-carboxypiperazine-4-yl)propyl-1-phosphate) | Trials (3-(2-carboxypiperazine-4-yl)propyl-1-phosphate) | Recent Studies (post-2010) (3-(2-carboxypiperazine-4-yl)propyl-1-phosphate) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | 3-(2-carboxypiperazine-4-yl)propyl-1-phosphate (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishikawa, T; Takahashi, K; Umino, A; Yoshida, Y | 1 |
1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)propyl-1-phosphate and oxidopamine
| Article | Year |
|---|---|
Evidence for N-methyl-D-aspartate receptor-mediated increase in norepinephrine utilization in the prefrontal cortex of unanesthetized rats.
Topics: 2-Amino-5-phosphonovalerate; Adrenergic Agents; Animals; Binding, Competitive; Consciousness; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Male; Microinjections; N-Methylaspartate; Norepinephrine; Oxidopamine; Phencyclidine; Piperazines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sympathomimetics; Tritium | 1997 |